However, breast cancer cells that express functional estrogen receptor (ER+) also have high expression of VDR and display enhanced sensitivity to treatment with the active form of vitamin D (1,25-dihydroxyvitamin D, 1,25D) [6]–[7]. This evidence concerns the gene ESR1 and breast cancer.